Michelle Morris, LPN

Horizon Oncology CenterLafayette, Indiana - 47905 (765-446-5111) |
- CLINICAL TRIALS 1
- CONDITIONS0
- INTERVENTIONS2
- SINCE2009

Study of EC0489 for the Treatment of Refractory or Metastatic Tumors
April 2009 - March 2011
Ec0489, Injection
Ec20



